Synaptonemal complex protein 3 is associated with lymphangiogenesis in non-small cell lung cancer patients with lymph node metastasis

Autor: Young Ho Lee, Stephen M. Hewitt, Seok Hyung Lee, Soo-Heang Eo, Junya Fukuoka, Jun Hanaoka, Shuhei Inoue, Tae Woo Kim, Chel Hun Choi, Kyung Hee Noh, Joon-Yong Chung, HyungJun Cho, Haruhisa Kitano
Jazyk: angličtina
Rok vydání: 2017
Předmět:
0301 basic medicine
Oncology
Male
Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factor B
Lung Neoplasms
SCP3
Vascular Endothelial Growth Factor C
Vascular Endothelial Growth Factor D
lcsh:Medicine
Cell Cycle Proteins
Metastasis
chemistry.chemical_compound
0302 clinical medicine
Non-small cell lung cancer
Carcinoma
Non-Small-Cell Lung

Medicine
Lymphangiogenesis
Lymph node
Nuclear Proteins
General Medicine
Middle Aged
Prognosis
Vascular endothelial growth factor B
Vascular endothelial growth factor
DNA-Binding Proteins
medicine.anatomical_structure
Vascular endothelial growth factor C
030220 oncology & carcinogenesis
Lymphatic Metastasis
Female
medicine.medical_specialty
Synaptonemal complex protein 3
General Biochemistry
Genetics and Molecular Biology

03 medical and health sciences
Internal medicine
Cell Line
Tumor

Humans
Lung cancer
Aged
Lymph node metastasis
business.industry
Research
lcsh:R
medicine.disease
Survival Analysis
030104 developmental biology
chemistry
Multivariate Analysis
business
Zdroj: Journal of Translational Medicine, Vol 15, Iss 1, Pp 1-10 (2017)
Journal of Translational Medicine
ISSN: 1479-5876
DOI: 10.1186/s12967-017-1241-5
Popis: Background The interaction of vascular endothelial growth factor-C (VEGF-C)/VEGF-D/VEGF receptor-3 is considered to be a major driver of lymphangiogenesis, however the mechanism of this process remains unclear. We aimed to investigate the possible lymphangiogenic significance of synaptonemal complex protein 3 (SCP3) in non-small cell lung cancer (NSCLC). Methods The expression of SCP3, VEGF-C, and VEGF-D were measured and examined a correlation between SCP3 and VEGF-C or VEGF-D in various human lung cancer cell lines. Subsequently, we assessed SCP3, VEGF-A, VEGF-B, VEGF-C, and VEGF-D expression in archival tumor tissues from 89 NSCLC patients with lymph node (LN) metastasis by combined immunohistochemistry with quantitative digital image analysis. Results Positive correlations between SCP3 and VEGF-C expression (R 2 = 0.743) and VEGF-D expression (R 2 = 0.932) were detected in various human lung cancer cell lines. The high expression of SCP3, VEGF-A, VEGF-B, VEGF-C, and VEGF-D were detected in 24 (27.0%), 22 (24.7%), 27 (30.3%), 27 (30.3%), and 24 cases (27.0%), respectively. Notably, SCP3 positively correlated with VEGF-C and VEGF-D expression (for both, P
Databáze: OpenAIRE